Both RSK1 and RSK2 had high mRNA expression in acute myeloid leukemia (LAML), GBM, pancreatic adenocarcinoma (PAAD), and stomach adenocarcinoma (STAD) patient data. This evidence concerns the gene RPS6KA1 and gastric adenocarcinoma.